Acquire Develop Out-License


Engaging with our industry and partners

  • News
  • Communications

Preliminary results of an ongoing Phase I/IIa first in human study

18 January 2023

Striving to improve treatment options for Acute Myeloid Leukaemia

21 December 2022

First patient dosed with EP0031

14 December 2022

Preliminary data from the phase 1/2 trial of EP0042 presented at ASH

12 December

Poster presentation of vosilasarm (EP0062) at SABCS

5 December 2022

Breast Cancer – Advancing Clinical Trial Design

1 December 2022

The Professor Gordon McVie Cancer Research Leaders Fellowship

24 November 2022

Ellipses Pharma to present clinical updates at leading U.S conferences

21 November 2022

FDA clearance of IND application for EP0031

22 June 2022

Exclusive licensing agreement

25 May 2022

Ellipses Brand Assets

Ellipses Brochure

Ellipses Business Development Brochure

Ellipses Scientific Affairs Group Brochure

Ellipses Scientific Affairs Group Animation

Professor Sir Christopher Evans OBE

Dr Rajan Jethwa

For all media enquiries, please get in touch

Contact us